PGL PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-04
full format · 92 days before the deadline
2025
31-12
Financial
Back to profitnet €47,372
The net result is €47,372, after one loss-making year.
31-12
Financial
Equity above €200,000equity €226,332 ▲26.5%
Equity rises from €178,960 to €226,332.
04-07
full format · 27 days before the deadline
16-01
Director discharge · Director appointment
2024
31-12
Financial
Weakest financial yearnet -€188,790
The net result drops to -€188,790, the lowest from 2022 to 2025. It recovers the following year.
26-07
full format · 5 days before the deadline
2023
31-12
Financial
Highest result from 2022 to 2025net €205,215 ▲74.6%
The operating result of €112,049 and the net result of €205,215 are both a record.
31-12
Financial
Equity above €200,000equity €367,750 ▲126%
With a profit in every financial year since 2022, equity grows to €367,750.
28-09
Representation rule · Other provision
30-06
full format · 31 days before the deadline
2022
22-08
Director discharge · Director appointment
2021
05-03
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank